Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.0%

1 terminated/withdrawn out of 49 trials

Success Rate

94.4%

+7.9% vs industry average

Late-Stage Pipeline

2 trials in Phase 3/4

Results Transparency

0 of 17 completed trials have results

Key Signals

19 recruiting

Enrollment Performance

Analytics

N/A

19(90.5%)

Phase 4

2(9.5%)

21Total

N/A(19)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (49)

Showing 20 of 49 trials

NCT07256249Recruiting

Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry

Role: lead

NCT07190690Not ApplicableRecruiting

Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

Role: lead

NCT05788432Active Not Recruiting

Sequent Extended Study

Role: lead

NCT05599061Not ApplicableActive Not Recruiting

Treatment of Functionally Non-significant Vulnerable Plaques in Patients With Multivessel ST-elevation Myocardial Infarction The VULNERABLE Trial

Role: lead

NCT07566624Recruiting

Spanish Prospective Registry of Hydra THV for Transcatheter Aortic Valve Implantation

Role: lead

NCT07286578Not ApplicableRecruiting

A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)

Role: lead

NCT06736899Not ApplicableRecruiting

Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions

Role: lead

NCT06321757Active Not Recruiting

PREVAIL Paclitaxel-coated Balloon in Small Coronary Disease and High-bleeding Risk Patients

Role: lead

NCT07399002Recruiting

LONG NAGOMI™ PMCF STUDY

Role: lead

NCT06863155Recruiting

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

Role: lead

NCT06657833Not ApplicableRecruiting

DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.

Role: lead

NCT06049654Not ApplicableRecruiting

Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication

Role: lead

NCT05698732Recruiting

Coroflex® ISAR NEO PMCF Study

Role: lead

NCT06214819Not ApplicableActive Not Recruiting

Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention.

Role: lead

NCT06448637Not ApplicableRecruiting

DRUG RELEASING BALL vs. PHARMACOACTIVE STENT IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY) IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY)

Role: lead

NCT06273293Not ApplicableRecruiting

Postprocedural Contrast Mediated FFR Plus Intracoronary Infusion of Nitroglycerin in Multivessel Patients (PROMETEUS TRIAL)

Role: lead

NCT06631157Recruiting

Essential Pro Study ( rEPIC04E-HK )

Role: lead

NCT04899141Active Not Recruiting

Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice

Role: lead

NCT04604197Not ApplicableActive Not Recruiting

ANGiographic Evaluation of Left Main Coronary Artery INtErvention